Company Overview and News

 
Altech Chemicals secures HPA plant site with final payment

2018-05-22 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC) (FRA:A3Y) has made its final payment for the four hectares of industrial land to host its proposed high purity alumina (HPA) plant in Johor, Malaysia.

 
Altech Chemicals receives US$120 million debt term sheet

2018-05-11 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC) (FRA:A3Y) has received a debt term sheet for up to US$120 million for its proposed high purity alumina (HPA) plant in Malaysia.

 
Altech Chemicals settles Meckering land purchase providing access to kaolin feedstock

2018-04-04 proactiveinvestors.com.au
Altech Chemicals Ltd’s (ASX:ATC) (FRA:A3Y) wholly-owned subsidiary Altech Meckering Pty Ltd has completed a land purchase central to development of the company's high purity alumina (HPA) project.

 
Altech Chemicals has key catalyst on the horizon as it trades at steep discount to broker valuations

2018-03-14 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC) made significant progress towards becoming one of the world's leading suppliers of 99.99% high purity alumina (HPA) in the last 12 months.

 
Altech closes in on securing project financing for alumina plant and feeder mine

2018-03-14 proactiveinvestors.com.au
Altech Ltd (ASX:ATC) continues to advance through the final stages of securing project finance for its proposed high purity alumina (HPA) plant in Malaysia.

 
Altech Chemicals patent application further protects high purity alumina technology

2018-02-27 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC) has lodged a new provisional patent application with the Australian Patent Office.

 
Altech Chemicals has manufacturing licence approved for HPA plant in Malaysia

2018-02-20 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC) has had its manufacturing licence for the proposed high purity alumina (HPA) plant in Johor, Malaysia approved.

 
Altech Chemicals finalises US$190 million finance package for Alumina plant

2018-02-02 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC) (FRA:A3Y) has formalised a total debt package of US$190 million for its proposed Malaysian high purity alumina (HPA) project.

 
Altech Chemicals sees heightened interest in its alumina project in Malaysia

2018-01-31 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC) is witnessing a heightened interest in its high purity alumina (HPA) project in Malaysia following the confirmation of project financing in late 2017 from German government-owned KfW IPEX-Bank.

 
Altech Chemicals submits manufacturing licence application in Malaysia

2018-01-09 proactiveinvestors.com.au
Altech Chemicals Ltd’s (ASX:ATC) wholly owned Malaysian subsidiary has submitted a manufacturing licence application in Malaysia for its proposed high purity alumina (HPA) plant.

 
Altech Chemicals receives additional support for high purity alumina

2017-12-20 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC,FRA:A3Y) remains focussed on becoming one of the world's leading suppliers of 99.99% (4N) high purity alumina (HPA) (Al2O3).  HPA is a high-value, high margin product as it is the critical ingredient required for the production of synthetic sapphire.

 
Altech Chemicals receives additional funding support for high purity alumina project

2017-12-20 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC,FRA:A3Y) remains focussed on becoming one of the world's leading suppliers of 99.99% (4N) high purity alumina (HPA) (Al2O3).  HPA is a high-value, high margin product as it is the critical ingredient required for the production of synthetic sapphire.

 
Altech Chemicals has a new substantial shareholder

2017-12-15 proactiveinvestors.com.au
The investment is related to the recently outlined equity support from German engineering firm SMS group GmbH.

 
Altech Chemicals shares rise as project financing is advanced

2017-12-15 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC) (FRA:A3Y) has been advised by the German government inter-ministerial committee (IMC) that it has reached a positive decision on its application for project finance export credit cover.

 
Altech Chemicals attracts US$11M funding for Malaysian alumina project

2017-11-09 proactiveinvestors.com.au
Altech Chemicals Ltd (ASX:ATC) has secured a commitment for an additional equity investment of US$11 million from German engineering firm SMS group GmbH.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...